Takeda proposes sale of IBD pipeline to close Shire deal
Takeda is in talks to sell Shire’s experimental inflammatory bowel disease pipeline in an effort to meet European regulators approval for the acquisition.
Archives for October 31, 2018
Lonza invests in ‘game-changer’ automated cell therapy manufacture
After a three-year partnership, Lonza pulled the trigger on acquiring a controlling stake of Octane Biotech and their jointly developed Cocoon system.